Literature DB >> 12585622

The impact of interventional neuroradiology on neurosurgical training.

R R Vindlacheruvu1, J E Dervin, P J Kane.   

Abstract

Aneurysmal subarachnoid haemorrhage carries a high mortality and morbidity. Surgical treatment (craniotomy and clipping of the aneurysm) has been, until recently, the gold standard treatment. Endovascular embolisation treatment has rapidly evolved and the evidence available suggests that the results are as good as surgery. Endovascular treatment successfully occludes the aneurysm to prevent re-haemorrhage, whilst reducing the procedural morbidity when compared to craniotomy and clipping. It is perceived to be of particular benefit for aneurysms in the posterior cerebral circulation where operative morbidity and mortality are significantly higher than for aneurysms on the anterior circle of Willis. The establishment of endovascular treatment has reduced the number of cases being treated surgically, and this has had a significant effect on surgical training. We analysed the management of all ruptured aneurysms treated in our unit over a 4-year period. During the same period, an endovascular service was established in the unit. We devised a novel system for the angiographic grading of aneurysms in order to evaluate the impact that coiling has had on surgical training. The results show that as few as four aneurysms per year would be appropriate for specialist registrars to operate upon. We propose some mechanisms for maintaining high quality surgical training.

Entities:  

Mesh:

Year:  2003        PMID: 12585622      PMCID: PMC1964337          DOI: 10.1308/003588403321001336

Source DB:  PubMed          Journal:  Ann R Coll Surg Engl        ISSN: 0035-8843            Impact factor:   1.891


  1 in total

1.  Implantation of 3D-Printed Patient-Specific Aneurysm Models into Cadaveric Specimens: A New Training Paradigm to Allow for Improvements in Cerebrovascular Surgery and Research.

Authors:  Arnau Benet; Julio Plata-Bello; Adib A Abla; Gabriel Acevedo-Bolton; David Saloner; Michael T Lawton
Journal:  Biomed Res Int       Date:  2015-10-11       Impact factor: 3.411

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.